The arbitration against Mylan continues to progress and it is worth noting Mylan has not submitted any counterclaims. The hearing is scheduled for fourth quarter 2017.
Possible settlement?
Multiple new TPM®/Oxymorphone patch candidates are on track towards stability testing in third quarter 2016.
Given that there’s only one month remaining in this quarter, it looks like tesa Labtec have been successful in coming up with multiple viable patch candidates.
Ann: Phosphagenics Half Year Financial Results-POH.AX, page-2
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $4.366K | 1.455M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 90468113 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 60283238 | 17 |
View Market Depth
| Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |